Hanson McClain Advisors »

Capricor Therapeutics shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Capricor Therapeutics (CAPR) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Capricor Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Capricor Therapeutics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Capricor Therapeutics by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $469 65 7.22
2025-06-30 $646 65 9.94

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Series Trust Prtflo S&p500 Gw (SPYG)
Spdr Series Trust Prtflo S&p500 Vl (SPYV)
Ishares Tr Us Treas Bd Etf (GOVT)
Apple Call Call Option (Principal) (AAPL)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Mbs Etf (MBB)
2023 Etf Series Trust Ii Gmo Us Quality E (QLTY)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Usd Inv Grde Etf (USIG)
Nvidia Corporation Call Call Option (Principal) (NVDA)

View all positions for Hanson McClain Advisors

Top funds holding Capricor Therapeutics

BlackRock
Vanguard Group
Susquehanna International
Citadel Advisors
Geode Capital Management
Caption Management
State Street Corporation
LMR Partners
J. Goldman & Co
Morgan Stanley
Pier Capital
DG Capital Management
Ikarian Capital
Millennium Management
National Bank Of Canada /fi/

View all funds holding Capricor Therapeutics